Clinical Trial Update: Clinical Evaluation of Metal Panel Allergens: Dose Response Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating dose response of metal panel allergens in dermatitis eczema, completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Dermatitis

Snippet

Sponsor: Allerderm | Conditions: Dermatitis, Eczematous | Phase 2 | Status: COMPLETED | Results posted: 2020-08-11